We are live on
!
Find out more
HPCM
High Pointe Capital Management Portfolio holdings
AUM
$139M
1-Year Est. Return
24.99%
This Fund
S&P 500
This Quarter
Est. Return
+11.67%
1 Year Est. Return
+24.99%
3 Year Est. Return
+92.38%
5 Year Est. Return
+133.03%
10 Year Est. Return
–
AUM
$84.3M
AUM Growth
+$11.3M
(+15%)
Cap. Flow
+$3.48M
Cap. Flow
% of AUM
4.13%
Top 10 Holdings %
Top 10 Hldgs %
31.27%
Holding
92
New
11
Increased
16
Reduced
27
Closed
12
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Curtiss-Wright
CW
|
+$1.67M |
| 2 |
Ziff Davis
ZD
|
+$1.52M |
| 3 |
FMC
FMC
|
+$1.28M |
| 4 |
Outfront Media
OUT
|
+$1.11M |
| 5 |
Agilent Technologies
A
|
+$851K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boston Scientific
BSX
|
+$1.57M |
| 2 |
FedEx
FDX
|
+$1.03M |
| 3 |
Johnson Controls International
JCI
|
+$765K |
| 4 |
DuPont de Nemours
DD
|
+$699K |
| 5 |
Chevron
CVX
|
+$695K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.69% |
| 2 | Materials | 15.94% |
| 3 | Industrials | 11.48% |
| 4 | Financials | 11.12% |
| 5 | Communication Services | 8.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Newmont
NEM
$96.2B
| $3.5M | 4.15% |
80,460
+4,570
| +6% | +$179K |
|
2
JPMorgan Chase
JPM
$916B
| $3.1M | 3.68% |
22,270
-140
| -0.6% | -$18K |
|
3
Bank of America
BAC
$429B
| $3.02M | 3.58% |
85,630
-1,170
| -1% | -$37.8K |
|
4
Bristol-Myers Squibb
BMY
$129B
| $2.89M | 3.43% |
45,026
+1,730
| +4% | +$99.1K |
|
5
CVS Health
CVS
$135B
| $2.71M | 3.22% |
36,540
-60
| -0.2% | -$4.21K |
|
|
6
FMC
FMC
$1.25B
| $2.61M | 3.09% |
26,120
+13,790
| +112% | +$1.28M |
|
|
AGN
7
DELISTED
Allergan plc
AGN
| $2.37M | 2.81% |
12,390
-60
| -0.5% | -$10.8K |
|
8
RTX Corp
RTX
$290B
| $2.1M | 2.49% |
22,310
-127
| -0.6% | -$11.5K |
|
9
Charter Communications
CHTR
$17.3B
| $2.08M | 2.46% |
4,280
-20
| -0.5% | -$9.2K |
|
|
ATVI
10
DELISTED
Activision Blizzard
ATVI
| $2M | 2.37% |
33,620
+2,790
| +9% | +$154K |
|
11
Booking.com
BKNG
$156B
| $1.91M | 2.27% |
23,275
+250
| +1% | +$19.6K |
|
12
Encompass Health
EHC
$11.3B
| $1.88M | 2.23% |
34,128
+12,068
| +55% | +$655K |
|
13
Regeneron Pharmaceuticals
REGN
$72.9B
| $1.74M | 2.07% |
4,640
+210
| +5% | +$70.7K |
|
|
14
Curtiss-Wright
CW
$25.1B
| $1.74M | 2.06% |
+12,315
| New | +$1.67M |
|
15
Jacobs Solutions
J
$16B
| $1.69M | 2.01% |
22,771
-133
| -0.6% | -$10.1K |
|
|
RTN
16
DELISTED
Raytheon Company
RTN
| $1.63M | 1.93% |
7,410
+30
| +0.4% | +$6.34K |
|
|
B
17
Barrick Mining
B
$60.9B
| $1.62M | 1.92% |
86,960
| – | – |
|
18
Nutrien
NTR
$33.9B
| $1.59M | 1.89% |
33,300
+13,910
| +72% | +$672K |
|
19
Centene
CNC
$30.5B
| $1.52M | 1.81% |
24,220
+5,100
| +27% | +$277K |
|
20
Comcast
CMCSA
$87.3B
| $1.51M | 1.79% |
33,520
-260
| -0.8% | -$11.6K |
|
|
21
Ziff Davis
ZD
$2B
| $1.5M | 1.78% |
+18,377
| New | +$1.52M |
|
22
HP
HPQ
$26B
| $1.48M | 1.75% |
71,910
-3,140
| -4% | -$59.5K |
|
23
Baker Hughes
BKR
$58.3B
| $1.47M | 1.75% |
57,420
+34,440
| +150% | +$783K |
|
24
AstraZeneca
AZN
$269B
| $1.46M | 1.73% |
14,650
| – | – |
|
25
Celanese
CE
$4.82B
| $1.44M | 1.7% |
11,660
-80
| -0.7% | -$9.85K |
|
Similar funds
COF
TC
FFA
NWM
KCA
RCM
SIS
MWM
High Pointe Capital Management's Q4 2019 Portfolio in Review
As of Q4 2019, High Pointe Capital Management held 92 positions worth $84.3M, up 15% from $73.1M the previous quarter. Its ten largest holdings account for 31% of the portfolio.
High Pointe Capital Management deployed $3.48M of net new capital in Q4 2019, opening 11 new positions and adding to 16 existing holdings. Its largest new stake was Curtiss-Wright: 12,315 shares worth $1.74M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 21% a quarter earlier, followed by Materials and Industrials.
On the sell side, the largest reduction was Chevron, an estimated $695K trimmed.
- High Pointe Capital Management's largest Q4 2019 buy was Curtiss-Wright: 12,315 shares worth $1.74M.
- High Pointe Capital Management added most to FMC in Q4 2019, an estimated $1.28M increase.
- High Pointe Capital Management's biggest Q4 2019 reduction was Chevron, cutting an estimated $695K.
- High Pointe Capital Management fully exited Boston Scientific in Q4 2019, selling an estimated $1.57M.
- High Pointe Capital Management's ten largest holdings make up 31% of its $84.3M portfolio in Q4 2019.
- High Pointe Capital Management opened 11 new positions and closed 12 in Q4 2019.
- High Pointe Capital Management's portfolio value rose 15% quarter-over-quarter to $84.3M.
Based on High Pointe Capital Management's 13F filing for Q4 2019, filed 12 Feb 2020.